The Synthetic Biology Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Tool (Oligonucleotides and Synthetic DNA, Enzymes, Cloning Technologies Kits, Synthetic Cells, Chassis Organisms, Xeno-nucleic Acids), By Technology (Gene Synthesis, Genome Engineering, Sequencing, Bioinformatics, Site-directed Mutagenesis, Cloning, Measurement and Modelling, Microfluidics, Nanotechnology), By Application (Medical Application, Artificial Tissue and Tissue Regeneration, Industrial Applications, Environmental Applications, Others).
Synthetic Biology is an interdisciplinary field that combines principles of biology, engineering, and computational science to design and construct artificial biological systems or redesign existing biological systems for specific purposes. This field involves the engineering of biological components such as DNA, RNA, proteins, and cells to create novel biological functions, pathways, or organisms with desired properties. Synthetic biology applications range from the development of microbial biofuels, bioremediation solutions, and agricultural biotechnology to the production of pharmaceuticals, biomaterials, and biosensors. Researchers in synthetic biology employ techniques such as DNA synthesis, genome editing, and metabolic engineering to engineer living organisms for diverse applications in healthcare, biomanufacturing, and environmental sustainability. With advances in genome editing tools, computational modeling, and automation technologies, synthetic biology holds promise for addressing global challenges in healthcare, food security, and environmental stewardship, driving innovations that could revolutionize various industries and improve quality of life worldwide.
A prominent trend in the synthetic biology market is the increasing application of synthetic biology techniques and tools in the fields of healthcare and pharmaceuticals. Synthetic biology involves the design and engineering of biological systems for various applications, including the development of novel therapeutics, diagnostics, and biomanufacturing processes. In healthcare, synthetic biology enables the creation of engineered cells and organisms for targeted drug delivery, gene therapy, and regenerative medicine. Moreover, the pharmaceutical industry is leveraging synthetic biology to streamline drug discovery and development processes, accelerate the production of biologics, and create novel bio-based materials. This trend reflects a growing recognition of the potential of synthetic biology to revolutionize healthcare and pharmaceuticals, driving increased investment and research in the field.
A key driver fueling the growth of the synthetic biology market is the growing demand for sustainable and eco-friendly solutions across various industries. Synthetic biology offers the potential to engineer biological systems to produce renewable fuels, chemicals, and materials using environmentally friendly processes. Companies and governments are increasingly investing in synthetic biology research and development to address pressing environmental challenges, such as climate change, resource depletion, and pollution. Additionally, synthetic biology holds promise for creating bio-based alternatives to fossil fuels, plastics, and other environmentally harmful products. As sustainability becomes a priority for businesses and consumers alike, the demand for synthetic biology solutions is expected to escalate, driving market growth and innovation.
An opportunity for growth in the synthetic biology market lies in expanding into industrial biotechnology and bio-based manufacturing sectors. Synthetic biology offers significant potential for optimizing industrial processes, improving product yields, and developing novel bio-based products across various industries, including agriculture, food and beverage, chemicals, and materials. By leveraging synthetic biology techniques, companies can engineer microorganisms to produce valuable compounds, enzymes, and materials more efficiently and sustainably than traditional chemical processes. Moreover, synthetic biology enables the development of customized biocatalysts and bioprocesses for the production of specialty chemicals, pharmaceutical intermediates, and biofuels. By tapping into the growing demand for bio-based alternatives and sustainable manufacturing solutions, companies can capitalize on the opportunities presented by industrial biotechnology and bio-based manufacturing, driving revenue growth and market expansion.
Within the Synthetic Biology market, the segment experiencing the fastest growth is Gene Synthesis. This growth can be attributed to several factors. Firstly, advancements in gene synthesis technologies have significantly reduced the cost and time required for custom DNA synthesis, making it more accessible to researchers and industries. Gene synthesis enables the creation of customized DNA sequences, facilitating various applications across medical, industrial, and environmental fields. In medical applications, gene synthesis plays a crucial role in gene therapy, drug development, and personalized medicine by enabling the production of specific DNA sequences tailored to individual patient needs. Moreover, in industrial and environmental sectors, gene synthesis is utilized for the production of biofuels, biochemicals, and environmental remediation through engineered microorganisms. As research and development in synthetic biology continue to expand, driven by advancements in gene synthesis technologies, this segment is expected to maintain its rapid growth trajectory, further propelling the overall synthetic biology market forward.
The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossAgilent Technologies Inc, Amyris Inc, Codexis Inc, Creative Enzymes, Eurofins Scientific SE, GenScript Biotech Corp, Ginkgo Bioworks Holdings Inc, Merck KGaA, Novozymes A/S, Precigen Inc, Synthego Corp, Synthetic Genomics Inc, Thermo Fisher Scientific Inc, Twist Bioscience Corp
By Tool
Oligonucleotides and Synthetic DNA
Enzymes
Cloning Technologies Kits
Synthetic Cells
Chassis Organisms
Xeno-nucleic Acids
By Technology
Gene Synthesis
Genome Engineering
Sequencing
Bioinformatics
Site-directed Mutagenesis
Cloning
Measurement and Modelling
Microfluidics
Nanotechnology
By Application
Medical Application
Artificial Tissue and Tissue Regeneration
Industrial Applications
Environmental Applications
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Agilent Technologies Inc
Amyris Inc
Codexis Inc
Creative Enzymes
Eurofins Scientific SE
GenScript Biotech Corp
Ginkgo Bioworks Holdings Inc
Merck KGaA
Novozymes A/S
Precigen Inc
Synthego Corp
Synthetic Genomics Inc
Thermo Fisher Scientific Inc
Twist Bioscience Corp
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Synthetic Biology Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Synthetic Biology Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Synthetic Biology Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Synthetic Biology Market Size Outlook, $ Million, 2021 to 2030
3.2 Synthetic Biology Market Outlook by Type, $ Million, 2021 to 2030
3.3 Synthetic Biology Market Outlook by Product, $ Million, 2021 to 2030
3.4 Synthetic Biology Market Outlook by Application, $ Million, 2021 to 2030
3.5 Synthetic Biology Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Synthetic Biology Industry
4.2 Key Market Trends in Synthetic Biology Industry
4.3 Potential Opportunities in Synthetic Biology Industry
4.4 Key Challenges in Synthetic Biology Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Synthetic Biology Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Synthetic Biology Market Outlook by Segments
7.1 Synthetic Biology Market Outlook by Segments, $ Million, 2021- 2030
By Tool
Oligonucleotides and Synthetic DNA
Enzymes
Cloning Technologies Kits
Synthetic Cells
Chassis Organisms
Xeno-nucleic Acids
By Technology
Gene Synthesis
Genome Engineering
Sequencing
Bioinformatics
Site-directed Mutagenesis
Cloning
Measurement and Modelling
Microfluidics
Nanotechnology
By Application
Medical Application
Artificial Tissue and Tissue Regeneration
Industrial Applications
Environmental Applications
Others
8 North America Synthetic Biology Market Analysis and Outlook To 2030
8.1 Introduction to North America Synthetic Biology Markets in 2024
8.2 North America Synthetic Biology Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Synthetic Biology Market size Outlook by Segments, 2021-2030
By Tool
Oligonucleotides and Synthetic DNA
Enzymes
Cloning Technologies Kits
Synthetic Cells
Chassis Organisms
Xeno-nucleic Acids
By Technology
Gene Synthesis
Genome Engineering
Sequencing
Bioinformatics
Site-directed Mutagenesis
Cloning
Measurement and Modelling
Microfluidics
Nanotechnology
By Application
Medical Application
Artificial Tissue and Tissue Regeneration
Industrial Applications
Environmental Applications
Others
9 Europe Synthetic Biology Market Analysis and Outlook To 2030
9.1 Introduction to Europe Synthetic Biology Markets in 2024
9.2 Europe Synthetic Biology Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Synthetic Biology Market Size Outlook by Segments, 2021-2030
By Tool
Oligonucleotides and Synthetic DNA
Enzymes
Cloning Technologies Kits
Synthetic Cells
Chassis Organisms
Xeno-nucleic Acids
By Technology
Gene Synthesis
Genome Engineering
Sequencing
Bioinformatics
Site-directed Mutagenesis
Cloning
Measurement and Modelling
Microfluidics
Nanotechnology
By Application
Medical Application
Artificial Tissue and Tissue Regeneration
Industrial Applications
Environmental Applications
Others
10 Asia Pacific Synthetic Biology Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Synthetic Biology Markets in 2024
10.2 Asia Pacific Synthetic Biology Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Synthetic Biology Market size Outlook by Segments, 2021-2030
By Tool
Oligonucleotides and Synthetic DNA
Enzymes
Cloning Technologies Kits
Synthetic Cells
Chassis Organisms
Xeno-nucleic Acids
By Technology
Gene Synthesis
Genome Engineering
Sequencing
Bioinformatics
Site-directed Mutagenesis
Cloning
Measurement and Modelling
Microfluidics
Nanotechnology
By Application
Medical Application
Artificial Tissue and Tissue Regeneration
Industrial Applications
Environmental Applications
Others
11 South America Synthetic Biology Market Analysis and Outlook To 2030
11.1 Introduction to South America Synthetic Biology Markets in 2024
11.2 South America Synthetic Biology Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Synthetic Biology Market size Outlook by Segments, 2021-2030
By Tool
Oligonucleotides and Synthetic DNA
Enzymes
Cloning Technologies Kits
Synthetic Cells
Chassis Organisms
Xeno-nucleic Acids
By Technology
Gene Synthesis
Genome Engineering
Sequencing
Bioinformatics
Site-directed Mutagenesis
Cloning
Measurement and Modelling
Microfluidics
Nanotechnology
By Application
Medical Application
Artificial Tissue and Tissue Regeneration
Industrial Applications
Environmental Applications
Others
12 Middle East and Africa Synthetic Biology Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Synthetic Biology Markets in 2024
12.2 Middle East and Africa Synthetic Biology Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Synthetic Biology Market size Outlook by Segments, 2021-2030
By Tool
Oligonucleotides and Synthetic DNA
Enzymes
Cloning Technologies Kits
Synthetic Cells
Chassis Organisms
Xeno-nucleic Acids
By Technology
Gene Synthesis
Genome Engineering
Sequencing
Bioinformatics
Site-directed Mutagenesis
Cloning
Measurement and Modelling
Microfluidics
Nanotechnology
By Application
Medical Application
Artificial Tissue and Tissue Regeneration
Industrial Applications
Environmental Applications
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Agilent Technologies Inc
Amyris Inc
Codexis Inc
Creative Enzymes
Eurofins Scientific SE
GenScript Biotech Corp
Ginkgo Bioworks Holdings Inc
Merck KGaA
Novozymes A/S
Precigen Inc
Synthego Corp
Synthetic Genomics Inc
Thermo Fisher Scientific Inc
Twist Bioscience Corp
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Tool
Oligonucleotides and Synthetic DNA
Enzymes
Cloning Technologies Kits
Synthetic Cells
Chassis Organisms
Xeno-nucleic Acids
By Technology
Gene Synthesis
Genome Engineering
Sequencing
Bioinformatics
Site-directed Mutagenesis
Cloning
Measurement and Modelling
Microfluidics
Nanotechnology
By Application
Medical Application
Artificial Tissue and Tissue Regeneration
Industrial Applications
Environmental Applications
Others
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
The global Synthetic Biology Market is one of the lucrative growth markets, poised to register a 24.1% growth (CAGR) between 2024 and 2030.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Agilent Technologies Inc, Amyris Inc, Codexis Inc, Creative Enzymes, Eurofins Scientific SE, GenScript Biotech Corp, Ginkgo Bioworks Holdings Inc, Merck KGaA, Novozymes A/S, Precigen Inc, Synthego Corp, Synthetic Genomics Inc, Thermo Fisher Scientific Inc, Twist Bioscience Corp
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume